Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder

Urology

Volumn 47, Issue 5, 1996, Pages 647-651

  Serretta, Vincenzo ^a,b   Piazza, S ^a   Pavone, C ^a   Piazza, B ^a   Pavone Macaluso, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; BCG VACCINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; MITOMYCIN; MITOXANTRONE; PEPTICHEMIO; THIOTEPA;

ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTECTOMY; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0029984046     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00007-6     Document Type: Article

References (15)

1. Boccon-Gibod L, Leleu C, Herve JM, Belas M, and Steg A: Bladder tumors invading the lamina propria (stage T1): influence of endovesical BCG therapy on recurrence and progression, in Debruyne FMJ, Denis L, and van der Meijden APM (Eds): BCG in Superficial Bladder Cancer. New York, Alan R. Liss, 1989, pp 161-170.
2. Vicente J, Laguna P, Duarte D, and Chechile G: Oncological identity of G3 pT1 bladder cancer. IXth Congress of the European Association of Urology, Amsterdam, June 13-16, 1990 (abstract 132), Eur Urol 18 (suppl 1): 69, 1990.
3. Pagano F, Garbeglio A, Milani C, Bassi P, and Pegorna A. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Eur Urol 13: 145-149, 1987.
4. Bouffioux CH: Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC-GU Group. Scand J Urol Nephrol 138: 167-177, 1991.
5. Pavone-Macaluso M, Pavone C, and Serretta V: Intravesical chemotherapy: update, in Williams RD (Ed): Treatment Perspectives in Urologic Oncology, New York, Pergamon Press, 1990, pp 135-147.
6. Gilbert HA, Logan JL, Kogan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lanni YW, Rowe JH, Cooper JF, et al: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J Urol 119: 488-492, 1978.
7. Cutler SJ, Heney NM, and Friedell GH: Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression, in Bonney WW, and Prouc GR (Eds): Bladder Cancer. Baltimore, Williams & Wilkins, 1980, pp 35-46.
8. Kurth KH, Denis L, Ten Kate FJ, Sylvester R, De Pauw M, Bouffioux CH, Debruyne FM, Pavone-Macaluso M, and Oosterlinck W: Prognostic factors in superficial bladder tumors. Prob Urol 6: 471-483, 1992.
9. Eure GR, Cundiff MR, and Schellhammer PF: Bacillus Calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J Urol 147: 376-379, 1992.
10. Lamm DL, and Griffith JG: Intravesical therapy: does it affect the natural history of superficial bladder cancer? Semin Urol 10: 39-44, 1992.
11. Herr HW: Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J Urol 145: 40-43, 1991.
12. Dal Bo V, Belmonte P, Veronesi A, Lo Re G, Miotto E, Merlo A, Volpe R, and Francini M: Intravesical BCG instillations in patients with carcinoma in situ and pT1, G3 transitional cell carcinoma of the bladder (abstract 82). Eur Urol 18 (suppl 1):43, 1990.
13. Morelli B, Randone DF, Terrone C, and Rocca Rossetti S: Quale' il miglior trattamento per il carcinoma vescicale di epitelio transizionale G3 T1. Acta Urol Ital 4: 155-156, 1992.
14. Bono AV, Benvenuti C, Damiano G, and Lovisolo J: Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1, G3 bladder cancer. Urology 44: 329-335, 1994.
15. Bouffioux CH, Denis L, Oosterlinck W, Viggiano G, Vergison B, Keuppens F, de Pauw M, Sylvester R, and Cheuvart B: Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European Organization for Research on Treatment of Cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary Group. J Urol 148: 297-301, 1992.